Sargent Bickham Lagudis LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2022$1,696
+69.6%
1000.0%0.00%
Q3 2022$1,000
-50.0%
1000.0%0.00%
Q2 2022$2,000
-33.3%
1000.0%0.00%
Q1 2022$3,000
-25.0%
1000.0%0.00%
Q4 2021$4,000
-20.0%
1000.0%0.00%
Q3 2021$5,0001000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders